My Recordable On-Demand Audio Discharge Instructions
MyROAD
1 other identifier
interventional
2,487
1 country
4
Brief Summary
Non-adherence to the heart failure (HF) plan of care after hospital discharge has been associated with clinical outcomes, including the combined endpoint of all-cause mortality and rehospitalization for decompensated HF. Patients and informal caregivers receive education materials but may not act due to multiple factors. A recorded message that could be repeatedly played by patients and caregivers might increase adherence to post-discharge self-care behaviors and early follow-up appointments, and have clinical benefits related to a reduction in all-cause mortality and rehospitalization. The purposes of this randomized, controlled study are to examine the effects of use of a novel MyROAD (Recordable On-Demand Audio Discharge) card, given to patients at discharge. The aims of this single-blind, placebo-controlled study are to examine the effects of recorded messages that can be replayed post discharge (delivered via the MyROAD card) on multiple subjective and objective clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2022
CompletedResults Posted
Study results publicly available
May 7, 2025
CompletedMay 7, 2025
April 1, 2025
4.6 years
September 1, 2016
April 11, 2023
April 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Patients Rehospitalized With Heart Failure
Number of patients re-hospitalized with heart failure.
30 day
Secondary Outcomes (15)
Number of Patients Scheduled for 7-day Follow-up Appointment With the Healthcare Provider Before Discharge
Discharge from hospital
Quality of Life (Health Status)
Baseline
Quality of Life (Health Status)
45 day
Symptoms
Baseline
Symptoms
45 days
- +10 more secondary outcomes
Study Arms (2)
MyRoad
EXPERIMENTALReceives usual care heart failure education before discharge AND a card at discharge that provided pre-recorded audio messages that can be played back on-demand on 4 themes: heart failure signs/symptoms assessment, medications, activity and exercise and diet and a general message about the importance of follow-up post discharge and following the plan of care.
Usual care
NO INTERVENTIONReceives usual care heart failure education before discharge
Interventions
Eligibility Criteria
You may qualify if:
- Not referred for cardiac transplantation or ventricular assist device during the index hospitalization,
- Minimum age 18 years (no upper age limit),
- Ability to read and write,
- Discharge to home or to a family member's home and has control of making self-care decisions,
- Willing to participate; which requires three (3) follow-up telephone calls post-discharge.
You may not qualify if:
- Chart documented psychiatric or cognitive conditions that limit ability to understand or adhere to self-care recommendations (Alzheimer's condition, dementia, schizophrenia, other neurological history that impairs memory),
- Plans to discharge to assisted living apartment/center, skilled nursing facility or hospice care center,
- Receiving home hospice or palliative care; or has a medical condition reflecting less than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV heart failure),
- Post-cardiac transplantation or ventricular assist device placement,
- Currently enrolled in another experimental heart failure research study,
- Chronic renal failure and receiving chronic hemodialysis therapy for an estimated glomerular filtration rate \< 30 mL/minute/1.73 m2,
- A non-traditional form of heart failure (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy).
- Wheelchair bound, uses a cane or walker, or unable to carry out physical activity, including walking,due to a chronic disability or documented medical condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- American Greetingscollaborator
Study Sites (4)
Cleveland Clinic main campus
Cleveland, Ohio, 44195, United States
Cleveland Clinic Fairview Hospital
Cleveland, Ohio, United States
Cleveland Clinic Hillcrest hospital
Mayfield Heights, Ohio, 44124, United States
Cleveland Clinic Medina Hospital
Medina, Ohio, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN
- Organization
- Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief Nursing officer, Nursing Research and Innovation
Study Record Dates
First Submitted
September 1, 2016
First Posted
September 15, 2016
Study Start
March 1, 2016
Primary Completion
September 30, 2020
Study Completion
March 30, 2022
Last Updated
May 7, 2025
Results First Posted
May 7, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share